Clinical & Experimental Immunology · 1992 · 36 citations · 24 references
MedicineImmunologyPathologyAutoimmunityImmunopathologyReproductive ImmunologyAntiphospholipid SyndromeAutoimmune Hematologic DiseaseCytokine BiologyCytokine-mediated PathologyCytokines In ReproductionSystemic Lupus ErythematosusAnti-phospholipid AntibodiesAntiphospholipid Syndrome - Associated ThrombocytopeniaAntiphospholipid Syndrome-associated Pregnancy LossPhospholipid Antibody SyndromePrimary Antiphospholipid SyndromeReproductive Outcome AssessmentSystemic Lupus Erythematosus Associations
Antiphospholipid syndrome (APLS) is characterized by thrombocytopenia, thromboembolic phenomena and recurrent fetal loss, associated with anti-cardiolipin antibodies (ACA) and/or lupus anticoagulant. The syndrome may be primary or may be associated with other conditions such as systemic lupus erythematosus (SLE). In this study we induced primary APLS following immunization of BALB/c mice with a human monoclonal ACA (H-3). Analysis of the cytokine profile of the mice with experimental APLS indicated low production of IL-2, IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) by concanavalin A (Con A)-stimulated splenocytes of H-3 immunized mice. It seems that the low levels of IL-3 and GM-CSF have a potential role in the fetal loss of the APLS. Whatever the mechanism of IL-3 and GM-CSF in preventing fetal loss, these results may have therapeutic bearing on the reproductive outcome in women and other species with APLS.
24
The "primary" antiphospholipid syndrome: major clinical and serological features.
Ronald A. Asherson, Munther A. Khamashta, José Ordi-Ros et al. · PubMed · 1989 · 897 citations
Medicine, Hematology, Immunology +17
Control of fetal survival in CBA × DBA/2 mice by lymphokine therapy
G. Chaouat, Elisabeth Menu, David A. Clark et al. · Reproduction · 1990 · 504 citations · Full text